{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T13:47:43Z","timestamp":1769521663575,"version":"3.49.0"},"reference-count":24,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T00:00:00Z","timestamp":1745712000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical University of Gdansk","award":["ST 01\u201310025 (0008288)"],"award-info":[{"award-number":["ST 01\u201310025 (0008288)"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infectious Disease Reports"],"abstract":"<jats:p>Background: Syphilis is an infectious systemic disease that remains a public health threat, with an increasing incidence worldwide. Despite the availability of diagnostic tests and effective treatments, achieving a serological cure remains challenging for some patients. Methods: A retrospective cohort study of 130 male patients with early syphilis who attended the Department of Dermatology Venereology and Allergology in Gdansk was carried out between 2021 and 2024. This study assessed the rates of proper serological response and seroreversion of the VDRL test during the posttreatment follow-up period and analyzed selected factors influencing the achievement of these points. Results: The treatment outcomes were favorable; 96.15% of the patients achieved a proper serological response at a median of 1.54 months and seroreversion of the VDRL test within 18 months (median time = 7 months). A significantly greater proper serological response was observed in the primary and secondary syphilis patients than in the early latent syphilis patients (p = 0.005). A proper serological response was associated with age over 30 years (risk ratio (RR) = 1.381, p = 0.008) and VDRL baseline titers (\u22651:32) (RR = 1.484, p = 0.005). The patients in the secondary or latent stage of early syphilis had a lower risk of seroreversion than those in the primary stage did (RR = 0.590, p = 0.030; RR = 0.560, p = 0.019, respectively). High titers at baseline (\u22651:32) were also associated with a 30.8% reduced risk of seroreversion compared with lower titers (RR = 0.692, p = 0.038). Conclusions: These results suggest that age, syphilis stage, and titer level are significant predictors of the response rate. Based on these results, it is recommended that serological follow-up be concentrated within the first three months posttreatment, as this period accounts for the majority of treatment responses.<\/jats:p>","DOI":"10.3390\/idr17030041","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T11:48:33Z","timestamp":1745840913000},"page":"41","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Analysis of Factors Determining Serologic Response to Treatment of Early Syphilis in Adult Men"],"prefix":"10.3390","volume":"17","author":[{"given":"Justyna","family":"Czarny","sequence":"first","affiliation":[{"name":"Department of Dermatology, Venerology and Allergology, Medical University of Gda\u0144sk, Mariana Smoluchowskiego 17 Street, 80-214 Gda\u0144sk, Poland"},{"name":"Department of Dermatology, Venereology and Allergology, University Clinical Centre, Mariana Smoluchowskiego 17 Street, 80-214 Gda\u0144sk, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damian","family":"Kadylak","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venerology and Allergology, Medical University of Gda\u0144sk, Mariana Smoluchowskiego 17 Street, 80-214 Gda\u0144sk, Poland"},{"name":"Department of Dermatology, Venereology and Allergology, University Clinical Centre, Mariana Smoluchowskiego 17 Street, 80-214 Gda\u0144sk, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u0142gorzata","family":"Soko\u0142owska-Wojdy\u0142o","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venerology and Allergology, Medical University of Gda\u0144sk, Mariana Smoluchowskiego 17 Street, 80-214 Gda\u0144sk, Poland"},{"name":"Department of Dermatology, Venereology and Allergology, University Clinical Centre, Mariana Smoluchowskiego 17 Street, 80-214 Gda\u0144sk, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4768-1387","authenticated-orcid":false,"given":"Roman J.","family":"Nowicki","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venerology and Allergology, Medical University of Gda\u0144sk, Mariana Smoluchowskiego 17 Street, 80-214 Gda\u0144sk, Poland"},{"name":"Department of Dermatology, Venereology and Allergology, University Clinical Centre, Mariana Smoluchowskiego 17 Street, 80-214 Gda\u0144sk, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,4,27]]},"reference":[{"key":"ref_1","unstructured":"WHO (2024, August 03). WHO Syphilis Fact Sheet. Available online: www.who.int\/news-room\/fact-sheets\/detail\/syphilis."},{"key":"ref_2","unstructured":"Chief Sanitary Inspectorate\u2014Department of Epidemic Prevention and Border Sanitary Protection, National Institute of Public Health NIH\u2014National Research Institute, Department of Epidemiology and Surveillance of Infectious Diseases (2024, April 26). Infectious Diseases and Poisonings in Poland in 2023, Warsaw, Poland, Available online: https:\/\/wwwold.pzh.gov.pl\/oldpage\/epimeld\/2023\/Ch_2023.pdf."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1001\/jama.2022.1246","article-title":"CDC Sexually Transmitted Infections Treatment Guidelines, 2021","volume":"327","author":"Hazra","year":"2022","journal-title":"JAMA"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1177\/09564624241280406","article-title":"BASHH UK guidelines for the management of syphilis 2024","volume":"35","author":"Kingston","year":"2024","journal-title":"Int. J. STD AIDS"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"563","DOI":"10.5114\/dr.2018.79169","article-title":"Syphilis. Diagnostic and therapeutic recommendations of the Polish Dermatological Society. Part 1: Early and late syphilis","volume":"105","author":"Pastuszczak","year":"2018","journal-title":"Dermatol. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/jdv.16946","article-title":"2020 European guideline on the management of syphilis","volume":"35","author":"Janier","year":"2021","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1093\/cid\/ciac060","article-title":"Management of Adult Syphilis: Key Questions to Inform the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment Guidelines","volume":"74","author":"Tuddenham","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1136\/sti.61.5.293","article-title":"Survival of Treponemes after Treatment: Comments, Clinical Conclusions, and Recommendations","volume":"61","author":"Dunlop","year":"1985","journal-title":"Sex. Transm. Infect."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1093\/cid\/ciad437","article-title":"State-of-the-Art Review: Neurosyphilis","volume":"78","author":"Hamill","year":"2024","journal-title":"Clin. Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1093\/cid\/cis757","article-title":"Serological response to treatment of syphilis according to disease stage and HIV status","volume":"55","author":"Knaute","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/sti.2006.021402","article-title":"Serological response to syphilis treatment in HIV-positive and HIV-negative patients attending sexually transmitted diseases clinics","volume":"83","author":"Ghanem","year":"2007","journal-title":"Sex. Transm. Infect."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1086\/644618","article-title":"Factors Determining Serologic Response to Treatment in Patients with Syphilis","volume":"49","author":"Guerrero","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.7326\/0003-4819-114-12-1005","article-title":"Serologic Response to Treatment of Infectious Syphilis","volume":"114","author":"Romanowski","year":"1991","journal-title":"Ann. Intern. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"ofy324","DOI":"10.1093\/ofid\/ofy324","article-title":"Incidence and predictors of serological treatment response in early and late syphilis among people living with HIV","volume":"6","author":"Spagnuolo","year":"2019","journal-title":"Open Forum Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Jinno, S., Anker, B., Kaur, P., Bristow, C.C., and Klausner, J.D. (2013). Predictors of serological failure after treatment in HIV-infected patients with early syphilis in the emerging Era of universal antiretroviral therapy use. BMC Infect. Dis., 13.","DOI":"10.1186\/1471-2334-13-605"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/cid\/cis918","article-title":"Response to therapy following retreatment of serofast early syphilis patients with benzathine penicillin","volume":"56","author":"Wolff","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1093\/cid\/cit146","article-title":"Syphilis treatment response among HIV-discordant couples in Zambia and Rwanda","volume":"56","author":"Karita","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1136\/sextrans-2012-050711","article-title":"Predictors of serological cure and serofast state after treatment in HIV-negative patients with early syphilis in China","volume":"89","author":"Li","year":"2013","journal-title":"Sex. Transm. Infect."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Tong, M.-L., Lin, L.-R., Liu, G.-L., Zhang, H.-L., Zeng, Y.-L., Zheng, W.-H., Liu, L.-L., and Yang, T.-C. (2013). Factors Associated with Serological Cure and the Serofast State of HIV-Negative Patients with Primary, Secondary, Latent, and Tertiary Syphilis. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0070102"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1136\/sextrans-2020-054887","article-title":"Clinical outcomes of syphilis in HIV-negative and HIV-positive MSM: Occurrence of repeat syphilis episodes and non-treponemal serology responses","volume":"98","author":"Nieuwenburg","year":"2022","journal-title":"Sex. Transm. Infect."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1258\/095646207782717018","article-title":"The outcome of treatment of early latent syphilis and syphilis with undetermined duration in HIV-infected and HIV-uninfected patients","volume":"18","author":"Manavi","year":"2007","journal-title":"Int. J. STD AIDS"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Marchese, V., Tiecco, G., Storti, S., Degli Antoni, M., Calza, S., Gulletta, M., Viola, F., Foc\u00e0, E., Matteelli, A., and Castelli, F. (2022). Syphilis Infections, Reinfections and Serological Response in a Large Italian Sexually Transmitted Disease Centre: A Monocentric Retrospective Study. J. Clin. Med., 11.","DOI":"10.3390\/jcm11247499"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Yang, C.-J., Lee, N.-Y., Chen, T.-C., Lin, Y.-H., Liang, S.-H., Lu, P.-L., Huang, W.-C., Tang, H.-J., Lee, C.-H., and Lin, H.-H. (2014). One dose versus three weekly doses of benzathine penicillin G for patients co-infected with Hiv and early syphilis: A multicenter, prospective observational study. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0109667"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/hiv.12985","article-title":"Predictors of serofast state after treatment for early syphilis in HIV-infected patients","volume":"22","author":"Paul","year":"2021","journal-title":"HIV Med."}],"container-title":["Infectious Disease Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2036-7449\/17\/3\/41\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:22:29Z","timestamp":1760030549000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2036-7449\/17\/3\/41"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,27]]},"references-count":24,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["idr17030041"],"URL":"https:\/\/doi.org\/10.3390\/idr17030041","relation":{},"ISSN":["2036-7449"],"issn-type":[{"value":"2036-7449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,27]]}}}